Pharmafile Logo
Pharmafocus logo
Advanced Search

Japan

Showing 7 posts of 82 posts found.

Eisai image

Eisai backs disease fund

July 12, 2013
Research and Development, Sales and Marketing Eisai, Japan, TB, partnership

A leading Japanese pharma group says that the sector should see investment in fighting diseases of the developing world as …

News

Olympus Biotech launches CMO services

October 9, 2012
Manufacturing and Production CMO, Japan, Olympus

US-based Olympus Biotech has launched a contract manufacturing organisation (CMO) operation to complement its current focus on regenerative medicines. The …

News

Shionogi opens UK office

July 9, 2012
Research and Development, Sales and Marketing Crestor, Japan, Osaka, Shionogi, cholesterol

Japanese pharma firm Shionogi & Co has opened a new office in London and pledged to expand into Europe. Osaka-based …

News
Japanese rescue workers

Japan’s pharma industry pledges to maintain medicines supply

March 17, 2011
Sales and Marketing Astellas, Boehringer Ingelheim, Daiichi Sankyo, Eisai, Japan, earthquake

Pharmaceutical firms in Japan have escaped the very worst of the devastation caused by the earthquake and tsunami, and have …

News

Sanofi boosts emerging markets leadership team

January 11, 2011
Sales and Marketing Brazil, China, Heraldo Marchezini, Japan, Jeremy Moulding Russia, Patrick Aghanian, Sanofi-Aventis, Thomas Kelly, appointments, emerging markets, sales and marketing

Sanofi-Aventis has bolstered its emerging markets team with the appointment of four senior managers. They are Patrick Aghanian, Thomas Kelly, …

Appointment

Pharma manufacturing news in brief

September 21, 2010
Manufacturing and Production AAIPharma, Actavis, Japan, KV Pharmaceutical, Purac, Takeda, contract manufacturing

This week’s round-up of pharmaceutical manufacturing news includes updates from Takeda, KV Pharmaceutical, Actavis, AAIPharma and Purac, while Japan’s CMOs …

News

Triple approval for Novartis in Japan

January 20, 2010
Sales and Marketing Afinitor, Asia, Exforge, Galvus, Japan, Novartis, hypertension

Japanese regulators have approved three new Novartis medicines for use patients with type II diabetes, high blood pressure and advanced …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025